Trial Profile
Study evaluating the utilization pattern and clinical outcomes of Ticagrelor compared to Prasugrel and Clopidogrel in patients following Percutaneous Coronary Intervention
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Sep 2018
Price :
$35
*
At a glance
- Drugs Ticagrelor (Primary) ; Clopidogrel; Prasugrel
- Indications Acute coronary syndromes
- Focus Therapeutic Use
- 21 Sep 2018 New trial record
- 26 Aug 2018 Results presented at the 34th International Conference on Pharmacoepidemiology and Therapeutic Risk Management